Fibrinolysis and COVID‐19: A plasmin paradox
Robert L. Medcalf, Charithani B. Keragala, Paul S. Myles
Topics & Concepts
FibrinolysisPlasminD-dimerHemostasisCoagulopathyFibrinCoronavirus disease 2019 (COVID-19)MedicinePandemicCoronavirusAntifibrinolyticThrombosisIntensive care medicineImmunologyDiseaseInternal medicineBiologyTranexamic acidInfectious disease (medical specialty)SurgeryBiochemistryEnzymeBlood lossCOVID-19 Clinical Research StudiesCOVID-19 and healthcare impactsDermatological and COVID-19 studies